What Is the ICD 10 Code for Onychomycosis? Find It Fast

The answer medical billers need is B35.1, Tinea unguium. Resilient MBS uses this ICD-10-CM code when the treating provider clearly documents onychomycosis or a fungal nail infection represented by the category. Finding the code is quick, but building an accurate and defensible claim requires a closer review of the documentation, procedure, units, modifiers, and payer requirements.[1]

Resilient MBS emphasizes that B35.1 identifies the diagnosis, not automatic coverage for every related service. A claim involving nail debridement, diagnostic testing, medication management, or surgery may require additional clinical details and payer-specific support before reimbursement can be expected.

What Does the ICD-10 Code B35.1 Represent?

Resilient MBS identifies B35.1 as the ICD-10-CM code for tinea unguium, the classification used for documented onychomycosis. The condition is a fungal infection that may affect a fingernail or toenail, although toenail infections occur more often.[1][2]

Resilient MBS notes that fungal nail infections may cause nails to become discolored, thick, fragile, cracked, or separated from the nail bed. These findings can support the provider’s assessment, but billing staff should not assign B35.1 from appearance alone because other conditions may produce similar nail changes.[2]

Does B35.1 Include Laterality or a Specific Nail?

Resilient MBS advises that B35.1 does not distinguish between the right and left side, fingernails and toenails, or individual digits. The code remains B35.1 regardless of which nail is affected.

Resilient MBS still recommends that providers identify the specific nail or nails in the medical record. That information may support the treatment plan, procedure selection, number of units, and medical-necessity review even though it is not built into the diagnosis code.

How to Use B35.1 Correctly

Resilient MBS recommends assigning B35.1 only when the provider documents a confirmed diagnosis such as onychomycosis, tinea unguium, or another fungal nail diagnosis represented by that code. A note stating only “thickened nail,” “yellow nail,” or “nail deformity” may not provide enough support.

Resilient MBS encourages a compliant provider query when the clinical assessment is unclear. Medical billing professionals should not convert symptoms or visual findings into a definitive fungal diagnosis simply because B35.1 appears likely to support reimbursement.

Use the Correct ICD-10-CM Version

Resilient MBS advises billers to use the ICD-10-CM code set applicable to the date of service. CMS guidance places responsibility on the provider to select codes from the code book appropriate to the year in which the service was rendered.[1]

Resilient MBS applies this rule when correcting older claims. A billing team should not automatically use the newest code file when working an encounter from a previous reporting year without first checking the applicable effective date.

Separate Diagnosis Coding From Procedure Coding

Resilient MBS distinguishes fungal infection coding from the procedure performed to evaluate or treat the condition. B35.1 reports the diagnosis, while the procedure code describes the service, such as an office visit, test, nail debridement, or surgical treatment.

Resilient MBS warns that a correct diagnosis code does not repair an incorrectly reported procedure, unsupported unit count, or missing modifier. Every element of the claim must match the patient-specific record.

Documentation Needed for Onychomycosis ICD-10 Billing

Resilient MBS recommends documentation that clearly connects the diagnosis to the services reported. A brief note can still be effective when it identifies the condition, affected nails, relevant findings, treatment plan, and clinical reason for any procedure.

Key Documentation Elements

Resilient MBS recommends reviewing each claim for the following:

• Resilient MBS confirms that the provider documented onychomycosis or tinea unguium.
• Resilient MBS verifies which fingernails or toenails are affected.
• Resilient MBS reviews findings such as discoloration, thickening, fragility, cracking, or separation.
• Resilient MBS checks for pain, infection, walking difficulty, or functional impairment when relevant.
• Resilient MBS confirms the number of nails treated when the procedure code depends on quantity.
• Resilient MBS validates secondary diagnoses and modifiers against the record and payer policy.

Resilient MBS advises against copying unchanged language into every visit. Patient-specific documentation strengthens medical billing compliance and gives reviewers a clearer explanation of what was evaluated and treated.

Is Diagnostic Testing Always Required?

Resilient MBS notes that CDC clinical guidance recommends diagnostic testing for suspected fungal nail infections before antifungal treatment because onychomycosis may be difficult to distinguish from other nail conditions.[2]

Resilient MBS does not treat this recommendation as proof that every B35.1 claim requires a separately billed laboratory test. The provider’s clinical decision, treatment plan, service billed, and payer policy determine whether testing is relevant and reimbursable.

Does B35.1 Automatically Support Nail Debridement?

Resilient MBS emphasizes that B35.1 alone may not establish medical necessity for nail debridement. Some Medicare billing articles require B35.1 plus another documented diagnosis indicating pain, secondary infection, difficulty walking, or another qualifying circumstance.[1]

Resilient MBS also recognizes that Medicare coverage requirements can vary by contractor and jurisdiction. A local policy used for one provider or location should not automatically be applied to every claim in Texas, Virginia, or another state.

Example of a High-Risk Claim

Resilient MBS may review a claim reporting B35.1 with nail debridement and find that the note documents fungal nails but does not identify the nails treated, the symptoms, the functional impact, or the medical necessity required by the applicable policy.

Resilient MBS would not correct that claim by adding unsupported diagnoses or modifiers. The proper response is to compare the record with the payer policy, verify the procedure and units, and request legitimate provider clarification when appropriate.

Common Onychomycosis Coding Errors

Resilient MBS sees preventable denials when billing teams focus on finding B35.1 but overlook the supporting claim details. The following errors can affect coding accuracy and revenue protection:

• Resilient MBS avoids assigning B35.1 from nail appearance without a documented diagnosis.
• Resilient MBS does not confuse onychomycosis with nail dystrophy, trauma, or another nail disorder.
• Resilient MBS does not assume B35.1 guarantees payment for a related procedure.
• Resilient MBS verifies that units match the number of nails documented as treated.
• Resilient MBS checks whether a secondary diagnosis or modifier is required.
• Resilient MBS avoids using an outdated code set or unrelated local coverage policy.
• Resilient MBS does not add diagnoses solely to reverse a denial.

Resilient MBS recommends tracking denials by provider, payer, procedure, diagnosis, modifier, and reason code. This approach helps a billing department identify whether the problem comes from documentation, coding, claim configuration, or payer-specific requirements.

Billing Implications for Texas and Virginia Practices

Resilient MBS uses B35.1 nationally because ICD-10-CM is a federal diagnosis classification system used across the United States. A documented case of onychomycosis does not receive a different ICD-10-CM diagnosis code simply because the provider is located in Texas or Virginia.

Resilient MBS still verifies the payer and jurisdiction before billing related procedures. Medicare Administrative Contractor policies, Medicaid requirements, managed-care rules, and commercial plan criteria may differ even when the diagnosis code remains the same.

Build an Audit-Ready Process

Resilient MBS recommends an audit-ready process rather than claiming that any billing workflow is completely “audit-proof.” A defensible claim should be supported by the current code set, patient-specific documentation, accurate procedure units, appropriate modifiers, and the relevant payer guidance.

Resilient MBS also advises practices to preserve the resources behind significant billing decisions. These records may include the applicable ICD-10-CM reference, coverage article, payer policy, remittance advice, and provider clarification.

Why Accurate Onychomycosis Billing Matters

Resilient MBS views diagnosis accuracy as part of the broader revenue cycle. One unsupported B35.1 claim may lead to a correction, but a repeated coding pattern can produce denials, staff rework, delayed payments, and greater compliance exposure.

Resilient MBS helps medical billing professionals distinguish between three separate questions: Is B35.1 the correct diagnosis code? Does the documentation support the diagnosis? Does the billed procedure meet the payer’s coverage requirements?

Resilient MBS positions education as the first step toward better claim performance. Teams that understand these distinctions can prepare cleaner claims, communicate more effectively with providers, and reduce avoidable billing errors without using aggressive or unsupported coding practices.

FAQs

What Is the ICD-10 Code for Onychomycosis?

Resilient MBS uses B35.1, Tinea unguium, when the provider clearly documents onychomycosis or a fungal nail infection represented by that ICD-10-CM category.

Can B35.1 Be Used for Both Fingernail and Toenail Fungus?

Resilient MBS confirms that B35.1 can represent fungal infections affecting fingernails or toenails. The code does not contain laterality or nail-specific detail, but the medical record should identify the affected nails.

Can a Medical Biller Assign B35.1 From Nail Discoloration?

Resilient MBS does not recommend assigning B35.1 from discoloration alone. The billing team should code the provider’s documented diagnosis because several fungal and nonfungal conditions may cause similar findings.

Does B35.1 Guarantee Payment for Nail Debridement?

Resilient MBS confirms that B35.1 does not guarantee coverage. The payer may require additional symptoms, diagnoses, documentation, units, systemic findings, or modifiers before debridement qualifies for payment.

Get Clearer Coding Guidance From Resilient MBS

Resilient MBS gives medical billing professionals a fast answer to what is the ICD 10 code for onychomycosis: B35.1. More importantly, Resilient MBS helps teams understand how documentation, medical necessity, procedure reporting, and payer policies affect the complete claim.

Resilient MBS invites practices to explore its educational resources or request a focused billing review to identify documentation gaps, coding risks, and recurring denial patterns affecting nail-care claims.